ANEMIA TREATMENT IN PATIENTS WITH STAGES III-V CHRONIC RENAL DISEASE
- Authors: Milovanov Y.1, Milovanova L.1, Kozlovskaya L.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 23, No 6 (2012)
- Pages: 61-63
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115478
- ID: 115478
Cite item
Open Access
Access granted
Abstract
The paper gives the results of using the original drug Venofer® to treat anemia in 146 patients with chronic renal disease, of whom 25 were on programmed hemodialysis (HD). The patients were followed up during a year, over which they received the original epoetin preparation Recormon subcutaneously and the orgininal iron drug Venofer ® intravenously. All the 146 patients with nephrogenic anemia who used epoetin preparations (Recormon) and intravenous iron (Venofer ®) could achieve the goal hemoglobin level of 110-120 mg/dl, thereafter the weekly dose of Recormon was halved compared to its starting dose of 60 IU/kg/week and the constancy of the body's iron level (TSAT>20%) in all the patients could be maintained with Venofer® 100 mg once every two weeks. In the patients on programmed HD, Venofer® was administered in a dose of 40 mg after each session or 100-200 mg once weekly. No serious complications were noted with the standard doses of Venofer ®.
Keywords
Full Text
About the authors
Yu. Milovanov
I.M. Sechenov First Moscow State Medical UniversityMD
L. Milovanova
I.M. Sechenov First Moscow State Medical UniversityCandidate of Medical Sciences
L. Kozlovskaya
I.M. Sechenov First Moscow State Medical UniversityProfessor, MD
References
- Mc Clellan W., Aronoff S., Bolton W. et al. The prevalence of anemia in patients with chronic kidney disease // Curr. Med. Ress. Opion. - 2004; 20: 1501-10.
- Российские национальные рекомендации по диагностике и лечению анемии при хронической болезни почек // Анемия. - 2006; 3: 3-18.
- Ермоленко В.М., Филатова Н.Н. Физиология метаболизма железа // Анемия. - 2004; 1: 3-10.
- Фесюк А.Ф., Мордик А.И. Борисова Е.В. Применение препарата Венофер® для коррекции дефицита железа у пациентов, находящихся на программном гемодиализе // Тер. арх. - 2003; 8: 59-61.
- Николаев А.Ю., Милованов Ю.С. Лечение почечной недостаточности. Руководство для врачей, 2-е изд. / М: МИА, 2011; 589 c.
- Нефрология. Национальное руководство / Под ред. Н.А. Мухина. -М.: ГЭОТАР-Медиа. - 2009; с. 191-203.
- Toblli J., Cao G., Oliveri L. et al. Differences between the original iron sucrose complex Venofer and the iron sucrose similar generis, and potential implications // Port. J. Nephrol. Hypert. - 2009; 23: 53-63.
- Toblli J., Cao G., Oliveri L. et al. Differences between the original intravenosus iron sucrose and iron sucrose similar preparations // Drug. Res. - 2009; 59: 176-90.
Supplementary files
